aTyr Pharma Inc.

NASDAQ: LIFE · Real-Time Price · USD
1.90
0.05 (2.70%)
At close: Jun 04, 2024, 10:00 PM

aTyr Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
235K 353K 10.39M n/a
Cost of Revenue
n/a 2.74M 1.7M 1.3M
Gross Profit
n/a -2.39M 8.69M -1.3M
Operating Income
-67.91M -54.92M -46.4M -34.02M
Interest Income
n/a n/a n/a n/a
Pretax Income
-64.02M -50.4M -45.34M -33.78M
Net Income
-64.02M -50.39M -44.28M -32.46M
Selling & General & Admin
13.78M 12.98M 13.98M 10.75M
Research & Development
54.37M 42.29M 42.81M 23.26M
Other Expenses
n/a 4.52M 1.06M 238K
Operating Expenses
68.15M 55.27M 56.79M 34.02M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 55.27M 56.79M 34.02M
Income Tax Expense
n/a n/a -1.07M -1.31M
Shares Outstanding (Basic)
75.8M 53.61M 28.42M 19.08M
Shares Outstanding (Diluted)
75.8M 53.61M 28.42M 19.08M
EPS (Basic)
-0.84 -0.94 -1.56 -1.7
EPS (Diluted)
-0.84 -0.94 -1.56 -1.7
EBITDA
-64.02M -52.18M -46.4M -34.02M
EBIT
-64.02M -54.92M -47.04M n/a
Depreciation & Amortization
n/a 2.74M 1.7M 1.3M